Pregnancy hormone offers hope to MS sufferers
A study involving mice showed that a hormone called prolactin triggers production of myelin, a fatty substance that protects nerve cells in the brain and spinal cord. In
The US Food and Drug Administration (FDA) has granted accelerated approval to Bristol Myers Squibb’s (BMS) Zenbexus (iberdomide), along with daratumumab and hyaluronidase-fihj and dexamethasone (ZDd), to treat adult multiple myeloma (MM) patients.
The eight-week multi-center, randomized, double-blind, placebo-controlled study enrolled 116 patients with poorly controlled systemic hypertension, approximately half with type 2 diabetes. Patients receiving placebo experienced a 6.4 mm